Tempest Therapeutics, Inc.
Records under this name other than the patents Tempest Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 8 of 8 · Back to Tempest Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,862,708 | Pyrazolone Compounds and Uses Thereof Lapsed on the fee record Ended Jan 9, 2022 · High confidence | Lapsed on the fee record | Ended Jan 9, 2022 | High confidence |
| US 9,776,976 | Triazolone Compounds and Uses Thereof Lapsed on the fee record Ended Oct 3, 2021 · High confidence | Lapsed on the fee record | Ended Oct 3, 2021 | High confidence |
| US 9,505,728 | Triazolone Compounds and Uses Thereof Lapsed on the fee record Ended Nov 29, 2020 · High confidence | Lapsed on the fee record | Ended Nov 29, 2020 | High confidence |
| 15/829,514 | Pyrazolone Compounds and Uses Thereof Abandoned Abandoned Apr 5, 2019 | Abandoned | Abandoned Apr 5, 2019 | |
| 18/002,557 | TREX1 Inhibitors and Uses Thereof Abandoned Abandoned May 13, 2025 | Abandoned | Abandoned May 13, 2025 | |
| 18/304,815 | Triazolone Compounds and Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/988,376 | Bicyclic Carboxamides and Methods of Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/891,116 | Crystalline Forms of a Ppar Alpha Antagonist Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |